• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Halozyme Therapeutics, Inc. (HALO)

    -NasdaqGS
    15.07 Down 0.21(1.37%) Feb 27, 4:00PM EST
    |After Hours : 15.06 Down 0.01 (0.03%) Feb 27, 4:36PM EST
    Add to Portfolio
    Prev Close:15.28
    Open:15.24
    Bid:8.75 x 100
    Ask:N/A
    1y Target Est:16.25
    Beta:0.89
    Next Earnings Date: 2-Mar-15HALO Earnings announcement
    Day's Range:14.86 - 15.34
    52wk Range:6.88 - 15.94
    Volume:724,341
    Avg Vol (3m):1,862,650
    Market Cap:1.87B
    P/E (ttm):N/A
    EPS (ttm):-0.71
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for HALO

    Comparison

    Symbol% ChgMkt Cap
    HALODown 1.37%1.87B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):32.99
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.58
    Quarterly EPS Est (Dec-14) :-0.07
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes human enzymes. Its research focuses on human enzymes that transiently modify tissue under the skin to facilitate the delivery of injected drugs and ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback